Placental kappa binding site : interaction with dynorphin and its possible implication in hCG secretion.

[1]  A. Valette,et al.  Purification and identification of multiple forms of dynorphin in human placenta , 1983, Neuropeptides.

[2]  M. Tafani,et al.  Localization of human placental opiate binding sites on the syncytial brush border membrane. , 1982, Life sciences.

[3]  C. Chavkin,et al.  Dynorphin is a specific endogenous ligand of the kappa opioid receptor. , 1982, Science.

[4]  A. Valette,et al.  Kappa opiate binding sites in human placenta. , 1981, Biochemical and biophysical research communications.

[5]  J. Rème,et al.  Specific binding for opiate-like drugs in the placenta. , 1980, Biochemical pharmacology.

[6]  S. Barnwell,et al.  Occurrence of methionine enkephalin in human placental villus. , 1980, Biochemical pharmacology.

[7]  J. Epelbaum,et al.  Met-enkephalin inhibition of K+-induced LHRH and ARIF release from rat mediobasal hypothalamic slices. , 1980, European journal of pharmacology.

[8]  Y. Nakai.  Presence of immunoreactive -lipotropin and -endorphin in human placenta , 1978 .

[9]  C. Kordon,et al.  Met-enkephalin inhibits in vitro dopamine-induced LHRH release from mediobasal hypothalamus of male rats , 1978, Nature.

[10]  J. Meites,et al.  Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone, follicle stimulating hormone, thyroid stimulating hormone and growth hormone. , 1977, Life sciences.

[11]  D. Coy,et al.  Stimulation of prolactin release in the rat by intraventricular injection of beta-endorphin and methionine-enkephalin. , 1977, Biochemical and biophysical research communications.

[12]  N. Ling,et al.  Stimulation in vivo of the secretion of prolactin and growth hormone by beta-endorphin. , 1977, Endocrinology.